Total Payments
$107,673
2024 Payments
$45,660
Companies
42
Transactions
1,280
Payment Breakdown by Category
Other$80,787 (75.0%)
Food & Beverage$19,454 (18.1%)
Consulting$4,480 (4.2%)
Travel$2,656 (2.5%)
Education$295.35 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,187 | 62 | 73.5% |
| Food and Beverage | $19,454 | 1,156 | 18.1% |
| Consulting Fee | $4,480 | 1 | 4.2% |
| Travel and Lodging | $2,656 | 4 | 2.5% |
| Honoraria | $1,600 | 1 | 1.5% |
| Education | $295.35 | 56 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $45,045 | 40 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $34,676 | 123 | $0 (2024) |
| ABBVIE INC. | $5,511 | 139 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $4,130 | 26 | $0 (2023) |
| Insulet Corporation | $3,321 | 250 | $0 (2024) |
| Dexcom, Inc. | $2,836 | 19 | $0 (2024) |
| PFIZER INC. | $1,979 | 35 | $0 (2024) |
| Novo Nordisk Inc | $1,894 | 96 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $911.87 | 82 | $0 (2023) |
| TOLMAR Pharmaceuticals, Inc. | $883.76 | 92 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,660 | 158 | SANOFI-AVENTIS U.S. LLC ($40,269) |
| 2023 | $13,303 | 174 | Alexion Pharmaceuticals, Inc. ($5,565) |
| 2022 | $9,106 | 212 | Alexion Pharmaceuticals, Inc. ($6,504) |
| 2021 | $6,897 | 152 | Alexion Pharmaceuticals, Inc. ($2,736) |
| 2020 | $6,764 | 142 | Alexion Pharmaceuticals, Inc. ($4,901) |
| 2019 | $15,758 | 156 | Alexion Pharmaceuticals, Inc. ($12,874) |
| 2018 | $6,546 | 142 | Dexcom, Inc. ($2,565) |
| 2017 | $3,638 | 144 | AbbVie, Inc. ($958.15) |
All Payment Transactions
1,280 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | CRENESSITY (Drug) | Food and Beverage | In-kind items and services | $38.30 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 12/12/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Growth Hormone | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $18.74 | General |
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes | ||||||
| 12/07/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Tolmar, Inc. | FENSOLVI (Drug) | Food and Beverage | Cash or cash equivalent | $27.29 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | PFIZER INC. | NGENLA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/21/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $11.38 | General |
| 11/14/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $21.37 | General |
| 11/12/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $614.57 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Endocrinology | ||||||
| 10/31/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Growth Hormone | ||||||
| 10/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.54 | General |
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $4,480.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
About Dr. Amy Burton, M.D
Dr. Amy Burton, M.D is a Pediatric Endocrinology healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154544054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Burton, M.D has received a total of $107,673 in payments from pharmaceutical and medical device companies, with $45,660 received in 2024. These payments were reported across 1,280 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,187).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Plano, TX
- Active Since 04/10/2007
- Last Updated 05/25/2023
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1154544054
Products in Payments
- TZIELD (Biological) $45,045
- Strensiq (Drug) $8,212
- STRENSIQ (Biological) $4,374
- t-slim insulin pump (Device) $4,004
- LUPRON DEPOT (Drug) $3,717
- Omnipod (Device) $3,321
- Dexcom CGM (Device) $2,565
- NGENLA (Drug) $1,368
- FENSOLVI (Drug) $1,309
- Lupron (Drug) $1,065
- BD Nano 2nd Gen Pen Needle (Device) $772.27
- GENOTROPIN (Drug) $594.08
- SKYTROFA (Drug) $586.70
- Triptodur (Drug) $532.83
- GVOKE PFS (Drug) $515.38
- SUPPRELIN (Drug) $509.57
- Sogroya (Biological) $447.19
- Norditropin (Drug) $435.95
- Norditropin (Biological) $387.69
- SUPPRELIN LA (Drug) $367.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.